Introduction
Fetal tissues are highly susceptible to tumor initiation by carcinogens, especially those that do not require metabolic activation (Anderson et al., 1985) . Lung is a particularly sensitive target in fetal mice of gestation days 13 ± 16. After transplacental exposure of mice to the direct-acting alkylating carcinogen, N-nitrosoethylurea (ENU) during this period, lung tumors develop with an exceptionally short latency, rapid growth rate, and tendency to malignancy, compared with tumors caused later in life by ENU or by other transplacental carcinogens such as urethane (Rice, 1969a,b; Branstetter et al., 1987 Branstetter et al., , 1988 Rehm et al., 1991) . ENU was found to distribute evenly and cause uniform levels of DNA ethyl adducts in fetal tissues at all times during gestation (Branstetter et al., 1987) , so the stage-speci®c eects of the chemical appear to be due to the tissue characteristics. Determination of the molecular events underlying this unique eect of ENU is desirable, not only in the context of special sensitivity of fetal tissues, but also because of the common occurrence of the homologous lung adenocarcinoma in humans.
K-ras mutations are commonly observed in human lung adenocarcinomas, and in mouse lung tumors initiated in fetuses or adults, and are early lesions found in hyperplasias as well as advanced cancers (Malkinson, 1992; Ichikawa et al., 1996; Horio et al., 1996; Westra et al., 1996) . Recently tumors induced in (AKR6NFS)F 1 mice, by transplacental ENU followed by postnatal exposure to the promoting agent butylated hydroxytoluene (BHT), were reported to contain mutations in the c-raf-1 oncogene, predominantly at codon 533 giving a serine to phenylalanine substitution, but, remarkably, no changes in K-ras (Storm and Rapp, 1993) . We undertook to con®rm this provocative result, starting with a somewhat simpler model in which BALB/c mice were given ENU or urethane on gestation days 14, 16 or 18. No mutations were found in c-raf-1, but unexpected, dramatic changes in the sensitivities of fetal lung K-ras codons 12 and 61 to mutation by ENU occurred with the progression of gestation from day 14 to day 18. This correlated with a marked increase in the amount and membrane localization of K-ras p21 protein in fetal mouse lungs between gestation days 16 and 18.
Results

Tumor type, incidence, multiplicity and size
The numbers of ospring examined at each time point and the pathological type of the tumors utilized for Kras mutation analysis are given in Table 1 . Tumors were diagnosed as adenomas or papillary adenocarcinomas, on the basis of heterogeneity, cellular and nuclear atypia, and local invasiveness (not shown). After transplacental ENU on gestation days 14 and 16, tumor incidence in the ospring reached 90 ± 100% by 24 weeks of age ( Figure 1 ). By contrast, after treatment on gestation day 18, tumor incidence was only 40% at 24 weeks, increasing progressively to 68 and 100% at 30 and 52 weeks, respectively, a signi®cant time-related trend (P50.005) and also signi®cantly dierent from the 24 week incidence values for the gestation day 14 and 16 exposure groups.
Eects of urethane on days 14 and 16 contrasted with those of ENU, with few tumors resulting and only with a long latency. Those initiated on day 18 showed a time course similar to the tumors initiated by ENU on day 18, with a maximum number of tumors occurring at 52 weeks.
Similar results were obtained with regard to tumor multiplicity ( Figure 2a ). Following ENU exposure at gestation day 14 or 16, multiplicity of lung tumors was already maximum at 24 weeks of age, whereas those exposed on gestation day 18 showed signi®cant increases in multiplicity through 52 weeks. Multiplicity of tumors tended to be highest after gestation day 16 exposure, signi®cantly so compared with day 18 exposure at all time points and compared with day 14 exposure at 52 weeks. After transplacental urethane, multiplicity was greatest after exposure on day 18, signi®cantly so at 52 weeks (Figure 2b ).
After ENU, average tumor sizes were remarkably uniform at a diameter of about 2 mm in most groups, with those arising after gestation day 16 treatment being somewhat smaller at 24 weeks, and those after gestation day 14 treatment being about twice as large at 52 weeks (Figure 3a) . Urethane-caused tumors, at 52 weeks, were signi®cantly larger after gestation day 18 treatment compared with days 14 and 16 ( Figure 3b ).
K-ras mutation spectrum
Analyses for mutant K-ras were carried out on tumors 4 mm or larger ( Table 2 ), except that, of the 16 tumors analysed after ENU/gestation day 18, half were less than 4 mm in size. The dierent mobility shifts in SSCP caused by mutations in the ®rst and second exons of K-ras are illustrated in Figure 4a and b, with sequence results in Figure 5a and b. Surrounding normal lung tissues from eight tumor-bearing animals and lung tissues from three treated animals with no lesion were also analysed by SSCP and no changes were detected (not shown).
The majority (91%) of the urethane-caused lung tumors analysed were found to have a mutant K-ras gene, all A : T to G : C mutations in codon 61 (Gln to Arg) (Figures 4b and 5b, Table 2 ).
Eects of ENU included this same A : T to G : C transition mutation in codon 61, with a frequency that increased signi®cantly as gestation progressed, from 16% on gestation day 14 to 69% on gestation day 18 (P50.01) ( Figure 4b , Table 2 ). Tumors caused by ENU exposure on gestation day 18 presented only this mutation in K-ras, with no codon 12 changes detected. The frequency of this mutation was the same for smaller tumors (54 mm, 5/8) as for larger ones (4 ± 7 mm, 6/8), and the average size of the tumors with codon 61 mutations was similar for gestation days 16 and 18 treatment.
By contrast, ENU given earlier in gestation caused a signi®cant number of tumors with codon 12 mutations. Among the 25 tumors analysed after ENU treatment on gestation day 14, codon 12 mutations predomi- Table 2 ). G : C to T : A transversions were most common, but G : C to A : T transitions and a G : C to C : G transversion also occurred. A tumor from a mouse exposed on gestation day 16 had a double mutation, G to C in the ®rst position and a G to T change in the second position of codon 12. Four tumors (from three dierent animals) from gestation day 14 ENU exposure were positive for both G to A and G to T changes at the second base of codon 12. For one of these animals, surrounding normal tissue was analysed and no mobility shift was detected in the SSCP pattern (not shown). Two of these animals presented multiple large tumors and little normal lung tissue, suggestive of merging of separate primary tumors. Thus it is likely that 29 tumors were actually represented, with 12 mutations (41%).
Expression of K-ras protein in fetal lung
In an attempt to correlate the shifts in sensitivity of codons 12 and 61 to mutation by ENU during lung maturation, with possible alterations in the expression of K-ras in fetal lung, we carried out immunoblot analysis. In BALB/c mice, the strain used for the transplacental carcinogenesis experiment described above, the amount of K-ras p21 was low in day 14 fetal lung, increasing progressively in lungs of day 16 and day 18 fetuses, with the greatest amount in adult lungs (Figure 6a ). This was apparent for total, membrane and cytosolic fractions, by factors of 6-, 2.8-and 16-fold, respectively, between gestation day 14 and day 18. A further 1.5 ± 2.2-fold increase was seen between gestation day 18 and adult lungs. To con®rm the generality of this ontogenetic change in mice, we carried out similar immunoblots with lungs from outbred NIH Swiss mice. Similar results were obtained (Figure 6b ), except that levels in day 14 and day 16 fetal lungs were similar, with 3 ± 5-fold increases between days 16 and 18. A further 2 ± 4-fold increase in membrane K-ras p21 was observed in adult Swiss lungs, compared with day 18 fetal lungs.
Analysis of c-raf mutation and expression
All tumors 4 mm or larger were assayed for c-raf-1 mutations by SSCP and none were found; representative results are shown in Figure 7 . Also, most of these tumors were analysed for raf m-RNA expression and no signi®cant dierences were noted ( Figure 8 ).
Discussion
Tumor data from this study con®rm the short latency of mouse lung tumors initiated by ENU on gestation days 14 ± 16, as compared with day 18, as previously described (see Introduction). However, although the greatest average size was achieved by tumors initiated on day 14, this was not apparent until 52 weeks. Latency and growth rate after 30 weeks appeared to be separable phenomena. The number of tumors were greatest after day 16 initiation by ENU; quantitative susceptibility of fetal mouse lung through day 16 correlates with the increase in numbers of cells at risk (Kauman, 1976) .
We report the ®rst evidence for qualitative and quantitative change in susceptibility to K-ras activation, correlated with the special ENU eects during pulmonary ontogenesis. The frequency of mutations in codons 12 and 61 underwent striking alteration with the progression of lung maturation, with codon 12 mutations decreasing, and codon 61 mutations increasing. Fetal mouse lung undergoes exponential growth and is morphologically undierentiated between gestation days 12 and 16. This is followed by a canalicular period on days 16 ± 17 and a terminal sac period (day 17 to birth) during which plateauing of growth and dierentiation of cells occur (see Vesselinovitch, 1973) . Thus, codon 12 was sensitive only during the period of rapid division of undierentiated cells, while susceptibility of codon 61 increased as the lung matured and growth rate slowed.
We hypothesized that these dierences could be related to alterations in expression of the K-ras gene, since a recent study showed lower expression of K-ras p21 in day 19 fetal rat lung compared with that of infants and adults (Thrane et al., 1997) . We have con®rmed this for both BALB/c and Swiss mice, and further shown that the level of this protein in fetal mouse lung on gestation day 14 is substantially lower than that on day 18, with further increases seen in adult lungs. The dierence was especially prominent for cytosolic ras p21 in BALB/c mice, suggesting that membrane/cytosol distribution as well as protein amount is developmentally regulated. The progressive increases in K-ras p21 in the BALB/c fetal lungs between gestation days 14, 16 and 18 correlate well with our observed changes in sensitivity to K-ras mutation by ENU over this period. The reason for the slightly dierent pattern in outbred Swiss mice is unknown but could relate to their greater average litter size .
Thus, codon 61 appeared to be at increased risk of A to G mutation, and codon 12 at decreased risk of a variety of changes, as K-ras gene expression increased during lung ontogeny. The codon 61 mutation was likely due to formation of O 4 -ethylthymine on the complementary antisense (transcribed) DNA strand, and this may have been more sensitive to ENU attack when the gene was more actively expressed on day 18. ENU alkylated an active gene to a greater extent than the bulk DNA in rat liver (Thomale et al., 1994) . O 4 -ethylthymine is known to be resistant to repair in rodents (see Samson et al., 1997) , so the known increased eectiveness of repair of transcribed genes (Hanawalt, 1996) would not oset a greater degree of ethylation. This same codon 61 mutation in K-ras has also been reported to be the predominant change in lung tumors caused by ENU or N-nitrosodiethylamine in adult strain A mice (You et al., 1992) .
The shift in codon 12 sensitivity, and the variety of mutations observed at this site, are more dicult to explain. G to A transitions in codon 12, expected from formation of O 6 -ethylguanine, were also found in mouse lung tumors after adult ENU treatment (You et al., 1992) . In contrast, the eight G to T and two G to C mutations found in codon 12 of K-ras in our study are unusual results of ENU treatment. These accounted for only 3 and 1%, respectively, of 401 mutations caused by ENU in ®ve types of assays (reviewed by Marker et al., 1997; see also Shibuya and Morimoto, 1993) . G to T and G to C mutations are, on the other hand, common results of metal-catalyzed reactive oxygen species (ROS) formation (Reid et al., 1994; Akasaka and Yamamoto, 1994) , and G to T mutation has been shown to result from formation of 8-oxo-dG (Le Page et al., 1995) . G to A transition may also occur as a result of ROS eects on ras (Kamiya et al., 1995; Jackson et al., 1997).
In strong support of some or all of the codon 12 mutations in our study being due to ROS, a recent study showed mutation in vitro of human K-ras contained in a plasmid and exposed to hydroxylradical generating systems [stimulated neutrophil plus iron or purine plus xanthine oxidase (Jackson et al., 1997] . Of 14 mutants obtained in codon 12, seven were G to T, ®ve were G to A, and one was G to C, a pro®le very similar to that in our study.
Although oxidative damage of DNA by ENU apparently has not been studied, various carcinogens including other nitroso compounds have been found to be eective in this regard (Ahotupa et al., 1987; Frenkel, 1992) , including the tobacco-speci®c nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in lung (Chung and Xu, 1992) . Recently we have shown increased 8-oxo-dG in fetal mouse liver and lung after transplacental exposure to NNK (Sipowicz et al., 1997) . Increased 8-oxo-dG was detected in rat liver after extraordinarily low doses of N-nitrosodiethylamine (1 mg/kg) (Nakae et al., 1997) .
In addition a number of other reports indirectly implicate ROS in K-ras mutation leading to lung tumorigenesis. Ozone caused lung tumors in mice, with a high frequency of K-ras mutations including G to T transversion in codon 12 (Sills et al., 1995) . Alveolar type II cells in rat lungs exposed intratracheally to inorganic particles, resulting in neutrophil and macrophage in®ltration, showed a large increase in HPRT mutations (Driscoll et al., 1997) .
K-ras in human lung adenocarcinomas, mutated in 30 ± 50% of cases, is also most frequently activated by G to T change, for example, 69% in a recent series, with 15% G to A and 16% G to C (Silini et al., 1994) . A DNA repair enzyme that excises oxidatively damaged guanine is localized to the short arm of human chromosome 3(3p25/26) in a region commonly deleted in lung cancer (Lu et al., 1997) . The protective eect of anti-oxidant containing fruits and vegetables in reducing the risk of lung cancer is also consistent (Ziegler et al., 1996) and continues to be supported by detailed studies (Mooney et al., 1997) .
Thus, while the smoking-related codon 12/13 K-ras mutations are generally ascribed to carcinogens such as NNK and benzpyrene (Homann et al., 1996) , ROS generated in association with metabolism of these compounds and the eects of other components of cigarette smoke, are also suspects. The high frequency of G to T transversions in the p53 tumor suppressor gene in lung cancers, related not only to cigarette smoke but also to metals exposure (Harty et al., 1996) further implicates ROS.
Involvement of nitric oxide (NO) is also a possibility, as NO may be a product of degradation of nitroso compounds including N-methylnitrosourea (Bartsch et al., 1989; Hill et al., 1975) , and is capable of causing all of the mutations that we observed. NO is produced by both macrophages and alveolar type 2 cells in adult lung (Warner et al., 1995) ; its presence in fetal lung has not been studied.
If our hypothesis is correct, why should codon 12 of K-ras in lung be more susceptible to mutation by ROS on gestation days 14 and 16 than day 18? One possibility relates to K-ras expression. The low expression of the gene on these days is likely to involve more tightly bound chromatin proteins, including histones, than is the case on day 18. It is possible that hydrogen peroxide, putatively a secondary product of membrane lipid damage due to ENU, is converted by the Fenton reaction to hydroxyl radical, catalyzed by iron bound to histones. Enhancement of 8-oxo-dG formation by metals bound to histones (Bal et al., 1996) or heterochromatin (Huang et al., 1995) has been demonstrated; in the latter study euchromatin was inhibitory. Other studies have indicated that DNA accessibility (Enright et al., 1996) and base sequence are important determinants of metal-catalyzed ROS damage. Eects of ROS on expressed vs nonexpressed genes have not been reported as yet. Although inclusion of 8-oxo-dG in both H-ras and K-ras caused G to T and G to A changes, leukocytederived hydrogen peroxide was unable to induce these changes in H-ras (Jackson et al., 1997) , con®rming the potential importance of secondary or tertiary chromatin structure for the interaction.
Other explanations for the disappearance of codon 12 sensitivity after gestation day 16 may include need for early clonal expansion for expression of these mutations, or, on gestation day 18, enhancement of transcription-coupled repair (Hanawalt, 1996) , reduction in cell division rate permitting more eective repair, and/or ontogenetic appearance of antioxidant defenses. Further work will be required to distinguish among these alternatives. This is a topic of considerable potential importance, since the mutations observed in codon 12 in our lung tumors were similar in pattern to those found in human lung adenocarcinomas. Thus the factors that control fetal mouse lung sensitivity to codon 12 mutation in K-ras could have wide implications for the etiology and management of human lung adenocarcinomas caused by tobacco smoke. It is even possible that some of these mutations originate in the fetal lung, as there has been at least one study linking adult lung cancer with maternal smoking (Correa et al., 1983) .
We cannot as yet conclude that the codon 12 mutations contributed to the early growth of the tumors initiated on gestation days 14 and 16 in our study, or have relevance to the signi®cantly poor prognosis of human lung adenocarcinomas with codon 12 K-ras mutations (Silini et al., 1994; Keohavong et al., 1996) . While the tumors appearing after gestation day 14 ENU exposure had the shortest latency and highest average size, and the highest frequency of codon 12 mutations, we have not yet established a correlation between these properties. Tumors containing the codon 12 mutations were not signi®cantly larger on average than those found with codon 61 mutation or no change in K-ras. It seems likely that other changes, as yet to be discovered, are contributory. Analysis of the smaller, 2 ± 3 mm tumors, may provide additional information. Urethane, which requires metabolism for activation, was eective only on day 18, probably due to the ontogenetic appearance of the activating enzyme(s) at that time . It caused only codon 61 mutations in K-ras. A : T to G : C transitions in codon 61 of K-ras are also common in adult mouse lung tumors caused by urethane, especially in BALB/c mice, although A to T transversions occurred as well and were more common in A/J mice and their hybrids (You et al., 1989; Re et al., 1992; Ohmori et al., 1992) and in the B6C3F1 hybrid (Kawano et al., 1995) .
We found no raf mutations in the ENU-induced tumors. The tumors studied by Storm and Rapp (1993) were in a dierent mouse strain and the protocol included postnatal treatment with the tumor promoter BHT. BHT promotion has been associated with reduced frequency of K-ras mutations (Matzinger et al., 1994) and so may somehow selectively encourage raf-mutant cells.
In summary our results indicate special, qualitatively unique sensitivity of fetal lung tissue to oncogene activation. Other evidence of special fetal sensitivity includes site-speci®c mutation of codons 12/13 of the H-ras oncogene in fetal mouse skin by cisplatin (Munoz et al., 1996) . Understanding of the factors that render mouse fetal lung brie¯y susceptible to Kras codon 12 mutation by ENU, during the glandularproliferative phase of development, and of the relationship of this responsiveness to K-ras gene expression, may shed important new light on susceptibility of both fetal tissues, and adult lung, to oncogene activation. Representative blots are shown. For (a), the average scan values+S.E. for gestation days 14, 16, and 18 and adult lung were 114+21, 291+24, 675+95, and 1480+87 for total; 181+27, 295+57, 499+50, and 735+103 for membrane; and 49+18, 193+34, 778+70, and 1233+193 for cytosolic K-ras p21. These values were all signi®cantly dierent (P50.05, ANOVA, Tukey-Kramer Multiple Comparison Tests, and Student's t tests) with the exception of day 14 vs day 16 for membrane (P=0.07). For (b), the average scan values were 160+33, 185+89, 668+170, and 1394+44 for total; 127+26, 53+6, 251+80, and 988+117 for membrane; and 146+57, 153+82, 419+249, and 824+363 for cytosolic K-ras p21. These values for total and membrane p21 were all signi®cantly dierent except for day 14 vs day 16, total p21, day 14 vs day 18, membrane p21. For the cytosolic fraction, day 14 and day 16 values were signi®cantly dierent from those for adult lung a b
Materials and methods
Animals
were examined the next morning for a vaginal plug (day 1 of gestation). Impregnated females were given either a single i.p. injection of 0.5 mmol ENU/kg or 1 mg urethane/ g on gestation day 14, 16, or 18 of gestation. ENU (Sigma) was dissolved in tricaprylin while urethane (Sigma) was dissolved in distilled water and both were administered at 0.1 ml/10 g. At 24 and 30 weeks, 8 ± 10 male and female ospring from each group were selected at random for interim kills, with the remainder killed at 52 weeks (see Table 1 ). A complete necropsy was performed. Lungs were inspected under a magnifying lens and the number and sizes (mm of largest dimension) of tumors recorded. All tumors 2 mm in largest dimension or bigger were frozen at 7808C for molecular analysis. Small slices of each along with adjacent normal lung parenchyma were ®xed in formalin, embedded in paran, cut at 6 mm and stained with H&E for pathological analysis.
For the study of K-ras p21 levels during ontogeny, timed pregnant BALB/c mice were obtained from APA, NCI-FCRDC. Eight week old adult Swiss mice (Cr : NIH) obtained from the APA were paired two females to one male for breeding and checked for vaginal plugs daily. Pregnant mice were sacri®ced on gestation days 14, 16 or 18 days of gestation and fetal lungs from each litter (8 ± 10 fetuses for Swiss and 6 ± 10 fetuses for BALB/c) were pooled.
Detection of K-ras mutation by PCR-cold SSCP analysis
DNAs from ENU-and urethane-induced tumors were initially screened for mobility shifts by PCR-SSCP analysis. Total RNA and high molecular weight DNA were extracted by Trizol (Gibco). 50 ± 100 ng of genomic DNA was mixed in PCR buer (10 mM Tris, pH 8.3, 50 mM KCl, and 1.5 mM MgCl 2 ) with 200 mM dNTP each, 0.2 mM of each 3' and 5' primer and 2.5 U AmpliTaq DNA polymerase (Perkin Elmer). To amplify a 181 bp product of K-ras exon 1, 5' primer 5'-TGATAATCTTGTGTGA-GACA-3' and 3' primer 5'-CTCTATCGTAGGGTCG-TACT-3' were used. A product of 142 bp was ampli®ed for exon 2 using the primers 5'-TTCTCAGGACTCCTA-CAG-3' and 5'-TATGGAAATACACAAAGAAA-3'. The samples were ampli®ed by PCR for 50 cycles. Each cycle consisted of 30 s denaturation at 958C, 30 s annealing at 558C, and 30 s extension at 728C. The ®nal extension step was done at 728C for 7 min.
The cold SSCP analysis was performed on duplicate PCR products according to the method of Hongyo et al. (1993) . Brie¯y, PCR products (20 ng) were denatured at 958C for 2 min with 20 mM methylmercury(II)hydroxide in a 20 ml volume and analysed by electrophoresis on 20% TBE gels (Novex), for 3 h at 268C and 258C for exons 1 and 2, respectively. The gels were stained with SYBR green II (Molecular Probe).
Representative samples for each SSCP mobility shift pattern were analysed for mutational change by direct PCR sequencing. PCR products were puri®ed by washing three times with water in a Microcon 50 spin column (Millipore) and were sequenced using the Circumvent thermal cycle DNA sequencing kit (New England Biolabs) according to the manufacturer's instructions. Sequencing primers for exons 1 and 2 of K-ras were the same as described for PCR reactions. One of the tumors had a faint but consistent signal in SSCP pattern (Figure 4a , lane 5). After increase of electrophoresis time to 4 h this band was punched out and reampli®ed for sequencing.
c-raf1 mutation analysis
Total mRNA was reverse transcribed to cDNA using murine leukemia virus reverse transcriptase in a 20 ml reaction volume; 1 mg of total RNA was mixed with reverse transcriptase buer, 1 mM of each dNTP, 5 mM MgCl 2 , 1 U RNase inhibitor, 2.5 U reverse transcriptase, and 2.5 mM random hexamer (Perkin Elmer RNA PCR kit). The reaction mixture was incubated for 30 min at 378C. The reverse transcriptase was heat inactivated at 958C for 5 min. Ten ml of this reaction mixture or 50 ± 100 ng of genomic DNA was subjected to PCR ampli®cation of raf exons. Positive control DNAs were ampli®ed from KS plasmid clones containing mutant raf. The latter was an RT ± PCR product of mutant raf from an ENU-induced, BHT-promoted lung tumor (kindly provided by U Rapp and S Storm). A 609 bp PCR product of c-raf1 exons 13 ± 17 was ampli®ed using 5'-AGGAGACCAAATTCCA-GATG-3' forward and 5'-GCGTGCAAGCATTGAT-GTCC-3' reverse primers. A 180 bp product of exon 14 and 15 was ampli®ed using 5'-GTTCTCAGCAGGTT-GAACAG-3' forward and 5'-TGGTCTCGGTTGT- TGATGTG-3' reverse primers. The latter set of primers was also used for ampli®cation of a 400 bp fragment of intron 15 and exon 15 from genomic DNA. The samples were subjected to 40 cycles each consisting of 958C, 608C and 728C for 1 min each and the ®nal extension for 7 min at 728C.
Cold SSCP conditions were established for analysis of raf mutations. The positive controls included both the single 533 serine-phenylalanine and the 533 serine-phenylalanine/543 alanine-threonine double mutants. Two dierent RT ± PCR products, a 609 bp fragment spanning exon 13 ± 17, and the other a 180 bp product spanning exons 14 and 15 were analysed for each tumor. A 400 bp PCR product from genomic DNA covering intron 15 and exon 15 was also analysed. Both RT ± PCR and PCR products of c-raf were analysed at 258C, and the running time varied from 3 ± 5 h, depending on the size of fragment analysed.
c-raf1 expression
We also examined these tumors for c-raf1 expression. RNA samples from ENU and urethane induced tumors were analysed by Northern blotting using a 2.5 kb HindIII mouse c-raf-1 cDNA fragment as probe. A 3.1 kb transcript of the expected size was expressed in normal lung tissue. Dierences in amounts of RNA loaded were estimated by probing for b-actin.
Immunoprecipitation and Western blotting of K-ras p21
For analysis of K-ras p21 in gestation day 14 lungs, each sample consisted of lungs pooled from three and four litters, for BALB/c mice and Swiss mice respectively, on gestation day 14. Lungs of one litter was pooled for each sample for gestation days 16 and 18. Individual lungs from adult 6-week old males were also used. Frozen lung tissues were homogenized in hypertonic buer containing 10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 10% sucrose, and the proteinase inhibitors aprotinin (0.1 TIU) and phenylmethylsulfonyl¯uoride (PMSF, 1 mM). The homogenate was centrifuged at 1000 g and the supernatant was divided in two halves. To one half of the supernatant 1/10th volume of 106 lysis buer [homogenization buer containing 10% Triton X-100, 1.5% sodium dodecyl sulfate (SDS) and 5% sodium deoxycholate] was added; this represented the total lysate. The other half was subjected to ultra centrifugation at 100 000 g. The cytosolic supernatant (S100) was separated from the membrane pellet (P100). The crude membrane pellet was washed three times by resuspension in the homogenizing buer and re-centrifugation, and then solubilized in membrane detergent lysis buer (10 mM Tris-HCl, pH 7.5, 1% Triton X-100, 0.1% SDS, 1.5 mM NaCl, aprotinin and PMSF). Protein contents were determined by BCA reagent (Pierce, Rockford, IL).
The total, cytosol and membrane lysate were adjusted to comparable protein concentrations, and 250 mg of total and membrane fraction protein and 500 mg of cytosolic fraction protein were immunoprecipitated using 30 ml of anti-v-H-ras agarose conjugated antibody (Oncogene Science) for 12 h at 48C. The immunoprecipitate was washed three times in the wash buer and resuspended in Lamelli buer containing 400 mM dithiothreitol (DTT). Samples were run on 12% Trisglycine polyacrylamide gels (Novex) at 100 V, and transferred to Hybond nitrocellulose membrane at 200 mA at 48C. The blot was blocked in 10% dry milk overnight at 48C and probed with anti-K-ras monoclonal antibody (OP24, Oncogene Science). The blots were incubated for 60 min at room temperature in secondary antibody (horseradish peroxidase labeled goat anti-mouse made in 1% gelatin, Amersham). After repeated washes in TBS containing 0.5% Tween-20 the blots were developed using a chemiluminescence ECL kit (Amersham) and exposed to X-ray ®lm. Results establishing the reproducibility of this method and linearity of results with protein concentration are being reported elsewhere (Ramakrishna and Anderson, 1998, Carcinogenesis) . Results were evaluated for statistical signi®cance using the Instat computer program (GraphPad, Inc.).
